Mugwort Allergy Shots (SCIT)
Mugwort allergy shots (SCIT) target the third most important pollen allergen source globally — a late-summer weed whose Art v 1 defensin protein connects respiratory allergy to celery-mugwort-spice syndrome, mugwort-mustard syndrome, and mugwort-peach LTP anaphylaxis. Art v 3 (heat-stable nsLTP) stratifies patients from OAS-level discomfort to epinephrine-requiring systemic reactions. A single Artemisia extract suffices for treatment due to greater-than-95% Art v 1 cross-reactivity across nine species.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Mugwortis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Mugwort Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to mugwort — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of mugwort allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of mugwort immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of mugwort extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for mugwort allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing mugwort extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription mugwort immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat mugwort allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Mugwort?
The biology, taxonomy, and clinical fingerprint of Mugwort — the foundation of how SCIT targets it.
Artemisia vulgaris pollen: wind-dispersed late-summer weed reaching peak counts of 10,000+ grains per cubic meter in European cities
- Scientific name
- Artemisia vulgaris
- Family
- AsteraceaeComposite / Daisy family
- Type
- Perennial weed pollen
- Native to
- Eurasia; naturalized throughout temperate North America
- Allergen proteins
- Art v 1 (major — defensin-like polyproline-linked protein, recognized by ≥95% of sensitized patients)Art v 3 (major — nsLTP, heat-stable, drives systemic food cross-reactivity)Art v 4 (profilin, pan-allergen)Art v 5 (polcalcin, pan-allergen)Art v 6 (pectate lyase — Amb a 1 homolog, mediates mugwort-ragweed cross-reactivity)
- Particle size
- 16–20 µm
- Avoidance difficulty
- Nearly impossible
How Mugwort Allergy Presents
Symptoms by body system — useful for distinguishing Mugwort sensitivity from overlapping allergies and infections.
Respiratory
- Profuse watery rhinorrhea during late July through September peak
- Severe nasal congestion with nocturnal snoring
- Allergic asthma exacerbations — mugwort can trigger bronchospasm in sensitized patients
- Post-nasal drip with chronic throat clearing
- Sinusitis from prolonged mucosal inflammation
Ocular
- Bilateral conjunctival injection with tearing
- Intense periocular itching
- Eyelid swelling during peak-count days
- Photophobia in severe conjunctivitis
Skin
- Oral tingling and lip swelling from raw celery, carrot, or stone fruit (OAS via Art v 1 / Art v 4)
- Urticaria after ingestion of foods cross-reactive via Art v 3 LTP
- Contact dermatitis from direct plant handling (Compositae sesquiterpene lactone pathway)
- Atopic dermatitis flare during pollen season in polysensitized patients
Systemic
- Food-induced anaphylaxis in Art v 3-sensitized patients — 48% of mugwort-food-allergic Chinese cohort experienced anaphylaxis (Gao et al. 2019)
- Celery-mugwort-spice syndrome: systemic reactions to celery, mustard, carrot, cumin, anise
- Mugwort-peach syndrome: Art v 3 / Pru p 3 LTP cross-reactivity with systemic potential
- Generalized urticaria and angioedema during high-count days in highly sensitized patients
When a patient presents with late-summer rhinitis plus a mystery reaction to celery, raw carrots, or stone fruit, mugwort molecular testing — specifically Art v 1 versus Art v 3 — separates the benign oral-itch crowd from the patients who need an epinephrine auto-injector before their next bowl of mustard-spiced lentil soup.
When & Where Mugwort Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: mid-August through mid-September in most temperate US zones· ~8–10 weeks of peak exposure; late July onset through October
US Exposure Map
19 high-intensity statesExposure intensity by state (text version)
- ME:
- High
- VT:
- High
- NH:
- High
- WA:
- Moderate
- MT:
- Moderate
- ND:
- Moderate
- MN:
- High
- WI:
- High
- MI:
- High
- NY:
- High
- MA:
- High
- OR:
- Moderate
- ID:
- Moderate
- WY:
- Moderate
- SD:
- Moderate
- IA:
- High
- IL:
- High
- IN:
- High
- OH:
- High
- PA:
- High
- NJ:
- High
- CT:
- High
- RI:
- High
- CA:
- Low
- NV:
- Low
- UT:
- Moderate
- CO:
- Moderate
- NE:
- Moderate
- MO:
- High
- KY:
- Moderate
- WV:
- Moderate
- VA:
- Moderate
- MD:
- High
- DE:
- High
- AZ:
- Low
- NM:
- Low
- KS:
- Moderate
- AR:
- Low
- TN:
- Moderate
- NC:
- Moderate
- SC:
- Low
- OK:
- Low
- LA:
- Low
- MS:
- Low
- AL:
- Low
- GA:
- Low
- TX:
- Low
- FL:
- Low
- AK:
- Low
- HI:
- Low
What Mugwort Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Mugwort sits at the center of the most complex pollen-food cross-reactivity network in late-summer allergy: Art v 1 (defensin) links mugwort to celery and spices, Art v 3 (heat-stable nsLTP) links it to peach and systemic food reactions, and Art v 6 (pectate lyase) links it to ragweed.
Greater-than-95% Art v 1 amino acid identity across Artemisia species — complete clinical cross-reactivity
Api g 7 (defensin-like celery allergen) correlates 0.86 with Art v 1; 87% of celery-allergic patients are mugwort-sensitized (Wüthrich 1990)
Celery-mugwort-spice syndrome component via Art v 1 / Art v 4 cross-reactivity
Mugwort-mustard syndrome — can produce more severe reactions than typical OAS due to LTP component
Mugwort-peach syndrome driven by Art v 3 / Pru p 3 LTP cross-reactivity — heat-stable, anaphylaxis risk
Celery-Mugwort-Spice Syndrome
Mugwort Art v 1 and Art v 4 cross-react with celery (Api g 7, Api g 4), carrot, parsley, fennel, coriander, cumin, anise, and mustard. The syndrome ranges from oral tingling (Art v 4 profilin-mediated, heat-labile) to systemic reactions requiring epinephrine (Art v 3 LTP-mediated, heat-stable). Component-resolved testing with Art v 1 versus Art v 3 determines which end of that spectrum a patient is on.
Is SCIT Right for Your Mugwort Allergy?
Answer five questions to estimate whether mugwort SCIT is likely to be a strong, moderate, or limited option for your situation.
How severe are your mugwort / late-summer pollen symptoms?
The Mugwort SCIT Protocol
Mugwort SCIT uses non-standardized Artemisia vulgaris extract (labeled in W/V or PNU/mL) because no FDA-standardized mugwort extract exists; a single species adequately covers the genus due to greater-than-95% Art v 1 cross-reactivity. Treatment should be initiated at least 12 weeks before late-July onset to establish tolerance before peak season.
The allergist progressively increases the extract concentration from the most dilute starting vial toward the target maintenance dose. With Curex, the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff, with a prescribed epinephrine auto-injector confirmed on hand and a brief self-observation afterward since systemic reactions almost always begin within the first 30 minutes. Build-up is often accelerated in the off-season (February–June) to reach maintenance before the August peak.
Once the target dose is reached, injection intervals extend to on a schedule individualized by your allergist. Symptom improvement typically begins in the first treated season and continues to build over years two and three. Patients co-sensitized to ragweed often receive a combined fall-weed vial including mugwort, ragweed, and marshelder.
After 3–5 years of successful maintenance, many patients achieve durable tolerance and can discontinue injections with sustained benefit. Patients with asthma comorbidity or Art v 3 LTP sensitization may benefit from longer courses before stopping. Symptom recurrence after stopping is managed by reinitiation of SCIT.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Mugwort SCIT
Artemisia SCIT has decades of European clinical experience and documented efficacy, though the evidence base is less extensive than for FDA-standardized allergens like short ragweed or timothy grass. Published studies support meaningful symptom and medication reduction over a 3–5 year course.
- Symptom score reduction (Artemisia SCIT vs. placebo)65%Tabar et al. 2005, Allergy — Artemisia SCIT randomized trial, N=48; 65% reduction in seasonal symptom scores at year 2
- Medication score reduction58%Tabar et al. 2005, Allergy — 58% reduction in rescue medication use over 2 years of active treatment
- IgE cross-reactivity across 9 Artemisia species95%Wopfner et al. 2008, Int Arch Allergy Immunol — ELISA inhibition: greater-than-95.4% Art v 1 amino acid identity; single-species extract sufficient
- Celery-allergic patients who are mugwort-sensitized87%Wüthrich et al. 1990, Schweiz Med Wochenschr — 87% of celery-food-allergic patients had positive mugwort IgE
Artemisia SCIT demonstrates clinically meaningful symptom and medication reduction in available trials, though the evidence base is smaller than for FDA-standardized allergens. The absence of a standardized extract limits cross-study comparison. Patients with concurrent Art v 3 LTP sensitization and food allergy should discuss whether SCIT adequately addresses the food-reaction component — it primarily targets the respiratory pathway.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Mugwort SCIT Side Effects
Mugwort SCIT side effects follow the standard inhalant SCIT profile. Non-standardized extracts may produce slightly variable local reaction rates across different lots; the 30-minute post-injection observation period is mandatory for all SCIT visits.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site swelling Wheel-and-flare reaction at injection site; typically resolves within 30 minutes | Rate 30–50% | Mild |
Injection-site itching | Rate 20–40% | Mild |
Injection-site redness | Rate 20–35% | Mild |
Large local reaction (>5 cm) Requires dose adjustment at next visit; not a reason to discontinue SCIT | Rate 5–10% | Moderate |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Rhinitis/conjunctivitis flare Managed with post-injection antihistamine when needed | Rate 1–3% | Mild |
Generalized urticaria | Rate 0.1–0.5% | Moderate |
Mild asthma exacerbation Peak flow monitoring before each injection recommended for asthmatic patients | Rate 0.1–0.5% | Moderate |
Anaphylaxis A prescribed epinephrine auto-injector is confirmed on hand; reactions typically begin within ~30 minutes, so Curex supervises the first injection from each new vial or concentration live in the Virtual Shot Room with a brief self-observation afterward | Rate <0.01% per injection | Severe |
Mugwort SCIT has a well-established safety record in European practice spanning several decades. Systemic reactions are rare with proper dose adjustment and pre-injection symptom screening. With Curex's at-home program the key safeguards are a personalized serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, the first injection from each new vial or concentration supervised live in the Virtual Shot Room by trained Curex clinical staff, and a brief post-injection self-observation since reactions almost always begin within the first 30 minutes.
SCIT vs Alternatives for Mugwort
Mugwort-allergic patients have four main options: SCIT (multi-year injection immunotherapy targeting the Artemisia-specific immune response), SLIT drops (off-label sublingual Artemisia extract), avoidance during late July–September (nearly impossible for outdoor workers), or daily antihistamines and nasal steroids (symptom suppression without disease modification).
| Criterion | At-Home SCIT (Curex)Best | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | 65%+ symptom reduction (Tabar 2005) | Moderate (extrapolated from grass/ragweed data) | Minimal — pollen disperses >100 miles | Symptom control only (not all patients respond) |
| 5-yr cost | $3,500–$8,000 out-of-pocket | Custom sublingual drops | Low direct cost | $300–$1,200/year |
| Duration | 3–5 years | 3–5 years | Seasonal only | Daily during season |
| Convenience | Weekly at home during build-up, then monthly — no clinic visits | Daily drops at home | Disrupts outdoor activity Aug–Sept | Convenient but daily burden |
| Safety | Systemic reaction <0.01%/injection | Lower systemic risk than injections | Complete | High — well-tolerated |
| Lasting effect | Durable — persists after stopping | Durable benefit expected | No lasting effect | No lasting effect after stopping |
At-Home SCIT (Curex)Best
SLIT
Avoidance
Medications
For patients with moderate-to-severe mugwort allergy who cannot commit to weekly clinic injections, Curex offers an at-home alternative: a personalized Artemisia immunotherapy delivered as a self-administered weekly shot with pricing confirmed in a current program quote that can combine mugwort with concurrent ragweed coverage — addressing the late-summer cross-reactive pollen complex that mugwort sits at the center of. The serum is sterile-compounded to USP <797>, a prescribed epinephrine auto-injector is confirmed on hand, and the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff.
What Mugwort SCIT Actually Costs
Most major insurers cover Artemisia SCIT under standard allergy immunotherapy benefits when ordered by a board-certified allergist with documented sensitization; coverage depends on individual plan deductible and co-insurance, and prior authorization may be required. Curex at-home IgE testing identifies specific mugwort sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; plus a copay for each video consultation, or $149/month self-pay with consultations included. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistSee if at-home mugwort allergy shots fit your symptoms
Curex offers at-home allergy shot treatment built around confirmed mugwort and related late-summer allergens.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Mugwort SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Mugwort (Artemisia vulgaris) is a weedy plant in the same family as ragweed that releases pollen in late summer. People sensitized to its main allergen, Art v 1, develop allergic rhinitis and conjunctivitis during mugwort season, and some also develop oral itching when eating certain foods like celery or carrot — known as celery-mugwort-spice syndrome — due to shared proteins between mugwort and those foods.
Mugwort and ragweed both peak in late summer and are both in the same plant family, but they are driven by completely different major allergen proteins. Mugwort's primary allergen is Art v 1, while ragweed's is Amb a 1. Some cross-reactivity exists, which can make differential diagnosis difficult without component-resolved testing. Mugwort is unique in causing celery-mugwort-spice syndrome and, less commonly, systemic food reactions — clinical patterns ragweed sensitization does not produce.
The answer depends on which mugwort allergen is driving your food reactions. Art v 1 and a related profilin protein mediate celery-mugwort-spice syndrome — these are generally heat-labile, producing oral itching and tingling that is usually benign. Mugwort SCIT primarily reduces the respiratory response and may provide some indirect benefit for these heat-labile food reactions. However, if your food reactions are driven by a heat-stable storage protein, SCIT has limited impact because that pathway is different. Component-resolved testing before starting SCIT clarifies your risk profile.
A board-certified allergist typically recommends starting the mugwort SCIT build-up phase at least 12 weeks before the anticipated season onset. Since mugwort peaks in late July through August in most of the US, starting the build-up in April or May allows time to reach or approach the maintenance dose before peak exposure. Even if you cannot start 12 weeks early, beginning SCIT in-season is still possible with a cautious, allergist-adjusted schedule.
Yes — because the main allergen proteins are highly similar across Artemisia species, SCIT with a single Artemisia species generally provides cross-protection across the genus. Patients primarily exposed to sagebrush in the Western US will typically benefit from either sagebrush or mugwort extract, and Western allergists often use sagebrush extract because it reflects local flora. Mugwort extract users elsewhere are similarly likely to be protected during travel-related sagebrush exposure.
Sublingual drops for mugwort are an off-label therapy in the US, since no mugwort SLIT tablet exists. The available evidence comes mainly from trials using other, well-studied allergens like timothy grass and ragweed. Drops generally show somewhat lower peak efficacy than shots in head-to-head comparisons, but they are taken at home, avoiding weekly clinic visits. For patients who cannot commit to the clinical schedule shots require, sublingual drops can be a meaningful alternative worth discussing with a board-certified allergist.
Yes — SCIT is appropriate for children typically aged 5 and older, and some allergists begin as early as age 3-4 in severe cases. Children with mugwort allergy and concurrent asthma or celery-mugwort-spice syndrome are often strong candidates because early intervention can modify disease course and may help prevent asthma escalation. The protocol uses the same concentration ladder as adults but may start more diluted, and careful post-injection observation is mandatory. A board-certified pediatric allergist should confirm mugwort as the primary sensitizer before starting SCIT in a child.
Missing one shot by a few days during the build-up phase is generally managed by resuming at the same dose under allergist guidance. Longer gaps during build-up, or extended gaps during maintenance, typically require a dose reduction to restart safely — the exact protocol depends on the length of the gap and your allergist's judgment. Contact your allergist's office before your next appointment if you have missed more than one injection.
Mugwort SCIT is typically covered under standard allergy immunotherapy benefits by most major US insurers when ordered by a board-certified allergist with documented sensitization. Coverage applies to both extract preparation and injection administration. Out-of-pocket costs vary substantially by plan deductible and co-insurance structure. Patients should confirm benefits with their insurer and ask whether prior authorization is required before starting the build-up series.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.